161 related articles for article (PubMed ID: 27274636)
1. Efficacy and Safety of Alitretinoin for Chronic Hand Eczema in Korean Patients.
Kwon HI; Kim JE; Ko JY; Ro YS
Ann Dermatol; 2016 Jun; 28(3):364-70. PubMed ID: 27274636
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Alitretinoin Therapy in Korean Elderly Patients with Chronic Hand Eczema: A Retrospective Single Center Study.
Jo M; Kang HS; Kim MS; Park HJ; Jue MS
Ann Dermatol; 2019 Dec; 31(6):595-600. PubMed ID: 33911658
[TBL] [Abstract][Full Text] [Related]
3. A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of alitretinoin (BAL4079) in the treatment of severe chronic hand eczema refractory to potent topical corticosteroid therapy.
Fowler JF; Graff O; Hamedani AG
J Drugs Dermatol; 2014 Oct; 13(10):1198-204. PubMed ID: 25607554
[TBL] [Abstract][Full Text] [Related]
4. An open-label study assessing the safety and efficacy of alitretinoin in patients with severe chronic hand eczema unresponsive to topical corticosteroids.
Dirschka T; Reich K; Bissonnette R; Maares J; Brown T; Diepgen TL
Clin Exp Dermatol; 2011 Mar; 36(2):149-54. PubMed ID: 21070335
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of alitretinoin depending on the concomitant use of topical corticosteroids in chronic hand eczema patients.
Cheon DU; Kim JE; Ko JY; Ro YS
J Dermatol; 2019 Nov; 46(11):998-1005. PubMed ID: 31535403
[TBL] [Abstract][Full Text] [Related]
6. The effectiveness of alitretinoin for the treatment of chronic hand eczema: A meta-analysis.
Al-Dhubaibi MS; Settin AA
Int J Health Sci (Qassim); 2018; 12(2):70-79. PubMed ID: 29599698
[TBL] [Abstract][Full Text] [Related]
7. DECISA Project (DErmatology Clinics in Italy: Survey on Alitretinoin): A real-life retrospective cohort multicenter study on 438 subjects with chronic hand eczema.
Ferrucci S; Persichini P; Gola M; Scandagli I; Pigatto P; Legori A; Musumeci ML; Micali G; D'Agata E; Schena D; Azzolini A; Gallo R; Trave I; Cristaudo A; Patruno C; Napolitano M; Zucca M; Piras V; Stingeni L; Bianchi L; Corazza M; Zedde P; Foti C; Romita P; Cannavò SP; Guarneri F
Dermatol Ther; 2021 May; 34(3):e14911. PubMed ID: 33619833
[TBL] [Abstract][Full Text] [Related]
8. Successful retreatment with alitretinoin in patients with relapsed chronic hand eczema.
Bissonnette R; Worm M; Gerlach B; Guenther L; Cambazard F; Ruzicka T; Maares J; Brown TC
Br J Dermatol; 2010 Feb; 162(2):420-6. PubMed ID: 19906075
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial.
Ruzicka T; Lynde CW; Jemec GB; Diepgen T; Berth-Jones J; Coenraads PJ; Kaszuba A; Bissonnette R; Varjonen E; Holló P; Cambazard F; Lahfa M; Elsner P; Nyberg F; Svensson A; Brown TC; Harsch M; Maares J
Br J Dermatol; 2008 Apr; 158(4):808-17. PubMed ID: 18294310
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of oral alitretinoin as treatment for chronic hand eczema in France: a real-life open-label study.
Halioua B; Paul C; Berbis P; Cambazard F; Doutre MS; Joly P; Richard MA; Aubin C; Gruber A; Chosidow O
Eur J Dermatol; 2019 Feb; 29(1):59-66. PubMed ID: 30827949
[TBL] [Abstract][Full Text] [Related]
11. Extended treatment with oral alitretinoin for patients with chronic hand eczema not fully responding to initial treatment.
Lynde C; Cambazard F; Ruzicka T; Sebastian M; Brown TC; Maares J
Clin Exp Dermatol; 2012 Oct; 37(7):712-7. PubMed ID: 22731739
[TBL] [Abstract][Full Text] [Related]
12. Alitretinoin for the treatment of severe chronic hand eczema.
Paulden M; Rodgers M; Griffin S; Slack R; Duffy S; Ingram JR; Woolacott N; Sculpher M
Health Technol Assess; 2010 May; 14 Suppl 1():39-46. PubMed ID: 20507802
[TBL] [Abstract][Full Text] [Related]
13. Safe and effective use of alitretinoin in children with recalcitrant hand eczema and other dermatoses - a retrospective analysis.
Luchsinger I; Vogler T; Schwieger-Briel A; Knöpfel N; Wälchli R; Weibel L; Theiler M
J Eur Acad Dermatol Venereol; 2020 May; 34(5):1037-1042. PubMed ID: 31742759
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics, efficacy and safety of alitretinoin in moderate or severe chronic hand eczema.
Schmitt-Hoffmann AH; Roos B; Sauer J; Spickermann J; Stoeckel K; Edwards D; van de Wetering J; Coenraads PJ; Maares J
Clin Exp Dermatol; 2011 Apr; 36 Suppl 2():29-34. PubMed ID: 21443602
[TBL] [Abstract][Full Text] [Related]
15. Impact on quality of life of alitretinoin in severe chronic hand eczema: FUGETTA real-world study.
Augustin M; Thaçi D; Kamps A
J Dtsch Dermatol Ges; 2016 Dec; 14(12):1261-1270. PubMed ID: 27992140
[TBL] [Abstract][Full Text] [Related]
16. Alitretinoin Compliance in Patients with Chronic Hand Eczema.
Seol JE; Kim JU; Hong SM; Cho GJ; Jin WJ; Park SH; Park IH; Jung SY; Kim H
Ann Dermatol; 2021 Feb; 33(1):46-51. PubMed ID: 33911811
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of topical delgocitinib in patients with chronic hand eczema: data from a randomized, double-blind, vehicle-controlled phase IIa study.
Worm M; Bauer A; Elsner P; Mahler V; Molin S; Nielsen TSS
Br J Dermatol; 2020 May; 182(5):1103-1110. PubMed ID: 31466119
[TBL] [Abstract][Full Text] [Related]
18. Comparative Study of Efficacy Between Cyclosporine and Alitretinoin in Patients With Chronic Hand Eczema.
Jang JH; Joh HC; Song CH; Kim KY; Jue MS; Ro YS; Ko JY
Dermatitis; 2024; 35(3):258-265. PubMed ID: 37870578
[No Abstract] [Full Text] [Related]
19. Study protocol: efficacy of oral alitretinoin versus oral cyclosporine A in patients with severe recurrent vesicular hand eczema (ALICsA): a randomised prospective open-label trial with blinded outcome assessment.
Oosterhaven JAF; Schuttelaar MLA
BMJ Open; 2018 Jul; 8(7):e020192. PubMed ID: 29997136
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of oral alitretinoin in patients with severe chronic hand eczema--a long-term analysis from a Swiss perspective.
Blank PR; Blank AA; Szucs TD
BMC Dermatol; 2010 Jun; 10():4. PubMed ID: 20579358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
